Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
BWAY Brainsway Ltd
- Stocks
- Healthcare
- NASDAQ: BWAY
Price (delayed)
$8.87
Market cap
$166.87M
P/E Ratio
49.28
Dividend/share
N/A
EPS
$0.18
Enterprise value
$102.88M
brainsway is a leading global neurmodulation company with headquarters in jerusalem and the us. our patented breakthrough technology has already treated over 10,000 patients, and has helped usher in a
Highlights
BWAY's net income has soared by 170% YoY and by 95% QoQ
BWAY's EPS has surged by 169% year-on-year and by 125% since the previous quarter
BWAY's quick ratio is up by 18% since the previous quarter but it is down by 6% year-on-year
Key stats
What are the main financial stats of BWAY
Market
Valuations
Earnings
Shares outstanding
18.81M
Market cap
$166.87M
Enterprise value
$102.88M
Price to earnings (P/E)
49.28
Price to book (P/B)
2.37
Price to sales (P/S)
3.59
EV/EBIT
20.68
EV/EBITDA
15.25
EV/Sales
2.51
Revenue
$41.02M
Gross profit
$30.58M
Operating income
$1.39M
Net income
$2.92M
EBIT
$4.98M
EBITDA
$6.75M
Free cash flow
$6.58M
Per share
Balance sheet
Liquidity
EPS
$0.18
EPS diluted
$0.1
Free cash flow per share
$0.4
Book value per share
$3.75
Revenue per share
$2.47
TBVPS
$5.67
Total assets
$94.32M
Total liabilities
$32M
Debt
$5.62M
Equity
$62.31M
Working capital
$64.32M
Debt to equity
0.09
Current ratio
5.19
Quick ratio
4.84
Net debt/EBITDA
-9.49
Margins
Efficiency
Dividend
EBITDA margin
16.4%
Gross margin
74.6%
Net margin
7.1%
Operating margin
3.4%
Return on assets
3.9%
Return on equity
6.1%
Return on invested capital
28%
Return on capital employed
6.3%
Return on sales
12.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
BWAY stock price
How has the Brainsway stock price performed over time
Intraday
1.84%
1 week
0.68%
1 month
4.72%
1 year
55.61%
YTD
-5.94%
QTD
-6.34%
Financial performance
How have Brainsway's revenue and profit performed over time
Revenue
$41.02M
Gross profit
$30.58M
Operating income
$1.39M
Net income
$2.92M
Gross margin
74.6%
Net margin
7.1%
BWAY's net income has soared by 170% YoY and by 95% QoQ
The company's net margin has surged by 154% YoY and by 82% QoQ
The operating income has soared by 128% YoY and by 22% from the previous quarter
Brainsway's operating margin has surged by 122% YoY and by 13% QoQ
Price vs fundamentals
How does BWAY's price correlate with its fundamentals
Growth
What is Brainsway's growth rate over time
Valuation
What is Brainsway stock price valuation
P/E
49.28
P/B
2.37
P/S
3.59
EV/EBIT
20.68
EV/EBITDA
15.25
EV/Sales
2.51
BWAY's EPS has surged by 169% year-on-year and by 125% since the previous quarter
The equity is up by 50% year-on-year and by 42% since the previous quarter
The P/B is 9% below the last 4 quarters average of 2.6 but 8% above the 5-year quarterly average of 2.2
The company's revenue rose by 29% YoY and by 6% QoQ
BWAY's P/S is 16% above its 5-year quarterly average of 3.1 and 9% above its last 4 quarters average of 3.3
Efficiency
How efficient is Brainsway business performance
The ROE has soared by 161% YoY and by 74% from the previous quarter
The ROA has soared by 157% YoY and by 70% from the previous quarter
BWAY's ROIC has soared by 87% QoQ
BWAY's return on sales is up by 26% since the previous quarter
Dividends
What is BWAY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for BWAY.
Financial health
How did Brainsway financials performed over time
The total assets is 195% greater than the total liabilities
Brainsway's total liabilities has increased by 50% YoY and by 14% QoQ
The total assets rose by 50% year-on-year and by 31% since the previous quarter
The company's debt is 91% lower than its equity
The equity is up by 50% year-on-year and by 42% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.